A chance conversation over a ‘cuppa,’ following a game of walking football, may just have saved the life of Clitheroe dad-of-two Peter Ward. Did you know with an ad-lite subscription to Burnley ...
Upcoming presentations at the ASCO meeting in Chicago highlight potential practice-changing studies in cancer care.
Olympus has signed a definitive agreement to acquire BioProtect for $270 million, adding biodegradable balloon spacer ...
Leading particle accelerator company expands portfolio of positron emission tomography diagnostics LANSING, Mich., May 26, 2026 (GLOBE ...
Doctors and scientists around the world are constantly searching for better ways to treat cancer. The goal is not only to help people live longer, but also to reduce side effects and improve quality ...
An investigator presented extended follow-up data from a phase 3 trial on aglatimagene besadenovec (CAN-2409) + prodrug in combination with standard-of-care EBRT in men with localized prostate cancer.
Telix to partner with companies developing advanced minimally invasive and image-guided ablative technologies for prostate cancer.Initial focus ...
Extended follow-up data from the phase 3 study (20 months after reported topline data, median follow-up 58 months) confirmed a statistically significant and clinically meaningful improvement in ...
Accelerating Domestic New Drug Development The Ministry of Food and Drug Safety approved *Rimqarto* (component name: Anbal kapta jen oto ryu sel), a personalized autologous T-cell (CAR-T) immune ...
In a randomized clinical trial, Mass General Brigham researchers found testosterone replacement therapy also improved quality of life for men who had undergone radical prostatectomy ...
Lupron Depot (leuprolide acetate) is a brand-name injection prescribed for prostate cancer and other hormone-related conditions. Lupron Depot’s side effects may vary depending on the dosage and the ...
Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver hormone therapy, according to the results of a large clinical trial led by UCL ...